SMURF1/2 Are Novel Regulators of WNK1 Stability
Angiogenesis is essential for remodeling and repairing existing vessels, and this process requires signaling pathways including those controlled by transforming growth factor beta (TGF-β). We have previously reported crosstalk between TGF-β and the protein kinase With No lysine (K) 1 (WNK1). Homozygous disruption of the gene encoding WNK1 results in lethality in mice near embryonic day E12 due to impaired angiogenesis, and this defect can be rescued by the endothelial-specific expression of an activated form of the WNK1 substrate kinase Oxidative Stress-Responsive 1 (OSR1). However, molecular processes regulated via a collaboration between TGF-β and WNK1/OSR1 are not well understood. Here, we show that WNK1 interacts with the E3 ubiquitin ligases SMURF1/2. In addition, we discovered that WNK1 regulates SMURF1/2 protein stability and vice versa. We also demonstrate that WNK1 activity regulates TGF-β receptor levels, in turn, controlling TGF-β signaling.
Authors
- Sakina A. Plumber (ORCID: https://orcid.org/0000-0003-4822-6765)
- Katherine Luby‐Phelps (ORCID: https://orcid.org/0000-0002-8378-1409)
- Ankita B. Jaykumar (ORCID: https://orcid.org/0000-0002-9396-5850)
- Melanie H. Cobb (ORCID: https://orcid.org/0000-0003-0833-5473)
- Chonlarat Wichaidit (ORCID: https://orcid.org/0000-0002-1012-4774)
- Derk D. Binns (ORCID: https://orcid.org/0000-0003-4949-3507)
Institutions
- Southwestern Medical Center (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Kinases and Phosphatases
- Published
- 2024-09-20
- DOI
- https://doi.org/10.3390/kinasesphosphatases2030019
- Primary Topic
- TGF-β signaling in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Welch Foundation
- American Heart Association
- Cancer Prevention and Research Institute of Texas
- University of Texas Southwestern Medical Center
- National Institutes of Health